fludarabine and Cryoglobulinemia

fludarabine has been researched along with Cryoglobulinemia in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (42.86)18.2507
2000's2 (28.57)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bhattacharyya, J; Kimura, A; Mihara, K; Takihara, Y1
Cacoub, P; Choquet, S; Decaux, O; Hermine, O; Jego, P; Karras, A; Pineton de Chambrun, M; Saadoun, D1
Appel, GB; Radhakrishnan, J; Rosenstock, JL; Sherman, WH; Stern, L1
Jacobs, MI; Mantha, S; Savage, DG1
Enzenauer, RJ; Judson, PH2
Zaja, F1

Other Studies

7 other study(ies) available for fludarabine and Cryoglobulinemia

ArticleYear
Successful treatment of IgM-monoclonal gammopathy of undetermined significance associated with cryoglobulinemia and cold agglutinin disease with immunochemotherapy with rituximab, fludarabine, and cyclophosphamide.
    Annals of hematology, 2012, Volume: 91, Issue:5

    Topics: Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cryoglobulinemia; Cyclophosphamide; Female; Humans; Immunoglobulin M; Livedo Reticularis; Middle Aged; Monoclonal Gammopathy of Undetermined Significance; Rituximab; Vidarabine

2012
Using rituximab plus fludarabine and cyclophosphamide as a treatment for refractory mixed cryoglobulinemia associated with lymphoma.
    Arthritis care & research, 2013, Volume: 65, Issue:4

    Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Cryoglobulinemia; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Myeloablative Agonists; Remission Induction; Retrospective Studies; Rituximab; Treatment Outcome; Vidarabine

2013
Fludarabine treatment of cryoglobulinemic glomerulonephritis.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2002, Volume: 40, Issue:3

    Topics: Adult; Cryoglobulinemia; Disease-Free Survival; Fatal Outcome; Female; Follow-Up Studies; Glomerulonephritis, Membranoproliferative; Hepacivirus; Hepatitis C, Chronic; Humans; Male; Middle Aged; RNA, Viral; Vidarabine; Viral Load

2002
Unusual leukemia presentations. Case 3. Type I IgGlambda cryoglobulinemia associated with chronic lymphocytic leukemia.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Aug-20, Volume: 23, Issue:24

    Topics: Allopurinol; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cryoglobulinemia; Diagnosis, Differential; Humans; Immunoglobulin G; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Rituximab; Vidarabine

2005
Type II mixed cryoglobulinemia treated with fludarabine.
    The Journal of rheumatology, 1996, Volume: 23, Issue:4

    Topics: Antineoplastic Agents; Cryoglobulinemia; Humans; Male; Middle Aged; Remission Induction; Sjogren's Syndrome; Vidarabine

1996
Fludarabine in the treatment of essential mixed cryoglobulinaemia.
    European journal of haematology, 1996, Volume: 57, Issue:3

    Topics: Antineoplastic Agents; Cryoglobulinemia; Humans; Vidarabine

1996
Purine analogues for treatment of refractory essential mixed cryoglobulinemia.
    Mayo Clinic proceedings, 1997, Volume: 72, Issue:1

    Topics: 2-Chloroadenosine; Cryoglobulinemia; Deoxyadenosines; Humans; Purines; Vidarabine

1997